Description
Wegovy 1mg pen is a semaglutide-based GLP-1 injection developed for chronic weight management in adults with obesity or overweight conditions. It works by mimicking the GLP-1 hormone to help regulate appetite, control cravings, and reduce caloric intake for sustainable results.
Key Features:
-
Prefilled 1mg weekly dose for intermediate treatment stages
-
Clinically proven to support effective weight management (NEJM study)
-
Easy-to-use, once-weekly injection pen
-
Promotes appetite control and metabolic balance
How To Use Wegovy 1mg Pen:
-
Inject once weekly, on the same day each week
-
Administer subcutaneously (abdomen, thigh, or upper arm)
-
Use Wegovy 1mg as a follow-up dosage after completing the 0.5mg stage, per healthcare provider guidance
Wegovy 1 mg Side Effects:
Mild side effects may include nausea, diarrhea, or fatigue as your body adjusts. Seek medical advice if side effects persist. Learn more at the FDA Wegovy Guide.
Storage Instructions:
-
Store refrigerated between 36°F–46°F (2°C–8°C)
-
Keep capped when not in use
-
Do not freeze or expose to heat




Reviews
There are no reviews yet.